Unknown

Dataset Information

Clozapine treatment and risk of COVID-19 infection: retrospective cohort study.


ABSTRACT:

Background

Clozapine, an antipsychotic with unique efficacy in treatment-resistant psychosis, is associated with increased susceptibility to infection, including pneumonia.

Aims

To investigate associations between clozapine treatment and increased risk of COVID-19 infection in patients with schizophrenia-spectrum disorders who are receiving antipsychotic medications in a geographically defined population in London, UK.

Method

Using information from South London and Maudsley NHS Foundation Trust (SLAM) clinical records, via the Clinical Record Interactive Search system, we identified 6309 individuals who had an ICD-10 diagnosis of schizophrenia-spectrum disorders and were taking antipsychotics at the time of the COVID-19 pandemic onset in the UK. People who were on clo

SUBMITTER: Govind R 

PROVIDER: S-EPMC7417985 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature